|Articles|May 1, 1996

Shifting Paradigms in the Treatment of Acid-Related Disorders
Volume 2
Issue 7 Suppl

Introduction

Author(s)Lawrence J. Brandt, MD

Download PDF: Introduction

Articles in this issue

almost 30 years ago

Article

Reflux Esophagitis/GERD

almost 30 years ago

Article

Duodenal/Gastric Ulcer

almost 30 years ago

Article

Analysis: PPIs and H2RAs

almost 30 years ago

Article

Interview

almost 30 years ago

Article

Selected Abstracts

almost 30 years ago

Article

CME Quiz

almost 30 years ago

Article

Gastroesophageal Disease

almost 30 years ago

Article

Goals and Objectives

almost 30 years ago

Article

Participating Faculty

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Latest CME

AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

On-Demand Virtual Symposium

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

On-Demand Virtual Symposium

Leveraging Managed Care to Optimize Patient Outcomes: Integrating Novel Treatments in Schizophrenia

1.5 Credits / Neurology, Psychiatry

Introduction

Articles in this issue

Newsletter

Related Content

Quality of Life: The Pending Outcome in Idiopathic Pulmonary Fibrosis

Increased Payments to Medicare Advantage Plans for Dually Eligible Beneficiaries

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

Building Trust: Public Priorities for Health Care AI Labeling

Ambient AI Tool Adoption in US Hospitals and Associated Factors

Latest CME

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

Leveraging Managed Care to Optimize Patient Outcomes: Integrating Novel Treatments in Schizophrenia

Trending on AJMC

FDA to Restrict Ingredients Used in Mass-Marketed Compounded GLP-1s, Crack Down on Misleading Ads

MID Models Reduce Adverse Events, Lower Costs in Oncology: Kenneth Komorny, PharmD, BCPS

TrumpRx Launch Brings Savings—and Uncertainty

Contributor: Reimagining Beneficiary Engagement in Accountable Care Models to Make America Healthy Again

5 Things to Know About the Oral GLP-1 Era